AMBQ
BEARISH
$25.36
Live
Ambiq Micro, Inc. · NYSE
Target $38.75
(+52.8%)
$22.12
52W Range
$51.76
At a glance
Key valuation, profitability, growth, and risk metrics.
Updated Mar 14, 2026
Market cap
$531.38M
P/E
N/A
ROE
-29.4%
Profit margin
-50.3%
Debt/Equity
0.0
Dividend yield
N/A
AI Analysis
AI-powered fundamental assessment
Confidence
85%
AMBQ exhibits severe financial distress signals, with a Piotroski F-Score of 1/9 indicating extreme operational weakness and no Altman Z-Score available, raising unquantified bankruptcy risk. Despite a strong gross margin of 44.26%, the company reports deep losses across all profitability metrics, including a -50.28% net profit margin and negative ROE/ROA. Insider selling of $0.55M in the last 6 months, coupled with a 34.2% decline over the past year, underscores deteriorating sentiment. While earnings surprises have been positive in recent quarters, they stem from shrinking losses rather than real profitability, and revenue growth is negligible at just 2% YoY. The stock trades at a premium valuation (Price/Sales: 7.33) despite negative earnings and no intrinsic value support.
Key Strengths
Strong gross margin of 44.26% indicates efficient production or product pricing
Positive earnings surprises in 3 of last 4 quarters suggest better-than-expected cost control or execution
No debt (Debt/Equity: 0.00) provides a clean balance sheet and eliminates interest risk
High current and quick ratios (8.76 and 7.69) indicate strong short-term liquidity
Analyst consensus is 'buy' with a target price of $38.75, implying upside potential
Key Risks
Piotroski F-Score of 1/9 signals severe financial distress and operational failure
Negative profitability across all metrics: net margin -50.28%, ROE -29.38%, ROA -17.11%
Forward P/E of -22.00 reflects continued losses and lack of earnings sustainability
Insider selling of $0.55M in 6 months, including a CTO, indicates internal skepticism
Stock has declined 34.2% over 1 year, 6 months, and 5 years, signaling persistent underperformance
Performance Snowflake
Multi-dimensional analysis across 5 key categories
Overall
21
Weak
20
40
30
15
0
AI Verdict
weak
Key drivers: Piotroski F-Score of 1/9, Negative profitability and earnings, High valuation relative to earnings, Declining price trend, Insider selling
Confidence
85%
Value
20/100
Stock trades at a premium valuation despite negative earnings and no intrinsic value support; premium justified only by speculative growth expectations.
Positives
- Price/Sales of 7.33 is below sector average (avg: 90.93 P/E, but no direct PS comparison)
- No debt provides valuation stability
Watchpoints
- No Graham Number or intrinsic value due to negative earnings
- Forward P/E of -22.00 implies no earnings to value
- Price/Sales of 7.33 is high for a loss-making company
- No cash flow or FCF data to support valuation
Future
40/100
Growth expectations are minimal; upside is speculative and not supported by fundamentals.
Positives
- Recent earnings surprises of up to 70.5% suggest potential for better-than-expected performance
- Analyst target price of $38.75 implies 53% upside from current price
Watchpoints
- Revenue growth is only 2.00% YoY, indicating stagnation
- Most recent Q/Q EPS growth is -45.5%, showing worsening profitability
- No forward guidance or growth catalysts evident
Past
30/100
Historical performance shows persistent underperformance and declining investor confidence despite short-term earnings beats.
Positives
- 3 of last 4 quarters beat earnings estimates
- Improving trend in earnings surprises (from -70.5% to +16.6%)
Watchpoints
- Consistently negative earnings across all periods
- 52-week high of $51.76 vs current $25.36 indicates significant decline
- 5-year, 3-year, 1-year, and 6-month returns all down 34.2% to 44.7%
Health
15/100
Despite strong liquidity, the company is unprofitable and failing on core operational metrics, with Piotroski F-Score signaling high risk of failure.
Positives
- Debt/Equity of 0.00 indicates no leverage risk
- Current and quick ratios are extremely high (8.76 and 7.69), indicating strong liquidity
Watchpoints
- Piotroski F-Score of 1/9 is the lowest possible, indicating severe financial distress
- Negative ROE, ROA, and ROIC suggest capital is not being deployed effectively
- No Altman Z-Score available, but the financial profile suggests distress risk
Dividend
0/100
No dividend policy exists; company is loss-making and cannot afford dividends.
Positives
No standout positives identified.
Watchpoints
- No dividend yield or payout ratio
- Dividend strength is 0/100
- Company is not distributing profits, and cannot due to losses
Stock Price & Analyst Targets
Real-time price movements and analyst price targets
Current Price
$25.36
Analyst Target
$38.75
Upside/Downside
+52.8%
Multi-Horizon Performance vs Peers
Price momentum across 5Y → 1W horizons for AMBQ and closest competitors.
Updated 2026-03-13
| Company | 5Y | 3Y | 1Y | 6M | 1M | 1W |
|---|---|---|---|---|---|---|
|
AMBQ
Ambiq Micro, Inc.
Primary
|
-34.2% | -34.2% | -34.2% | -26.4% | -13.5% | -10.7% |
|
HKD
AMTD Digital Inc.
Peer
|
-89.6% | -79.9% | -19.5% | -4.5% | +12.7% | -6.1% |
|
MLAB
Mesa Laboratories, Inc.
Peer
|
-61.0% | -39.5% | -13.6% | +43.8% | +25.5% | +3.8% |
|
CINT
CI&T Inc.
Peer
|
-76.7% | +5.8% | -20.3% | -14.7% | -12.6% | -10.8% |
|
RDVT
Red Violet, Inc.
Peer
|
+90.6% | +145.8% | +7.3% | -23.2% | -0.5% | +11.0% |
AMB
Ambiq Micro, Inc.
Primary
5Y
-34.2%
3Y
-34.2%
1Y
-34.2%
6M
-26.4%
1M
-13.5%
1W
-10.7%
HKD
AMTD Digital Inc.
Peer
5Y
-89.6%
3Y
-79.9%
1Y
-19.5%
6M
-4.5%
1M
+12.7%
1W
-6.1%
MLA
Mesa Laboratories, Inc.
Peer
5Y
-61.0%
3Y
-39.5%
1Y
-13.6%
6M
+43.8%
1M
+25.5%
1W
+3.8%
CIN
CI&T Inc.
Peer
5Y
-76.7%
3Y
+5.8%
1Y
-20.3%
6M
-14.7%
1M
-12.6%
1W
-10.8%
RDV
Red Violet, Inc.
Peer
5Y
+90.6%
3Y
+145.8%
1Y
+7.3%
6M
-23.2%
1M
-0.5%
1W
+11.0%
Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.
Historical Performance Trends
Long-term financial metrics and growth patterns
Revenue & Net Income
Profit & Operating Margins
Return on Equity (ROE)
Quarterly Revenue Growth
Historical data shows last 12 quarters (3 years)
Valuation Metrics
Key valuation ratios and pricing indicators
P/E Ratio
N/A
Forward P/E
-22.0
PEG Ratio
N/A
P/B Ratio
2.86
P/S Ratio
7.33
EV/Revenue
5.51
EV/EBITDA
-12.36
Market Cap
$531.38M
Profitability
Profit margins and return metrics
Profit Margin
-50.28%
Operating Margin
-57.66%
Gross Margin
44.26%
ROE
-29.38%
ROA
-17.11%
Growth
Revenue and earnings growth rates
Revenue Growth
+2.0%
Earnings Growth
N/A
Q/Q Revenue Growth
N/A
Q/Q Earnings Growth
N/A
Financial Health
Balance sheet strength and liquidity metrics
Debt/Equity
0.0
Low debt
Current Ratio
8.76
Strong
Quick Ratio
7.69
Excellent
Cash/Share
$6.6
Financial Statement Flow
Interactive flow visualization showing how money moves through the company Q3 2025
Revenue
$0.0B
Gross Margin
42.3%
Op. Margin
-55.3%
Net Margin
-49.6%
Total Assets
$0.2B
Liabilities
$0.0B
Equity
$0.2B
Debt/Equity
0.10x
Operating CF
$-0.0B
CapEx
$-0.0B
Free Cash Flow
$-0.0B
FCF Yield
134%
Quarterly Earnings History
EPS performance vs analyst estimates
2026-05-05
$N/A
2026-03-05
$-0.32
+16.6% surprise
2025-11-06
$-0.22
+30.1% surprise
2025-09-04
$-0.13
+70.5% surprise
Technology Sector Comparison
Comparing AMBQ against 565 companies in the Technology sector
(45 bullish, 197 neutral, 323 bearish)
Return on Equity (ROE)
-29.38%
This Stock
vs
-33.47%
Sector Avg
-12.2%
(Below Avg)
Profit Margin
-50.28%
This Stock
vs
-11.75%
Sector Avg
+328.0%
(Superior)
Debt to Equity
0.0
This Stock
vs
0.74
Sector Avg
-99.4%
(Less Debt)
Revenue Growth
2.0%
This Stock
vs
4383.21%
Sector Avg
-100.0%
(Slower)
Current Ratio
8.76
This Stock
vs
3.59
Sector Avg
+144.2%
(Stronger)
Similar Companies
Peer comparison within the same industry
| Company | AI Rating | Market Cap | P/E | ROE | Profit Margin | Price | |
|---|---|---|---|---|---|---|---|
|
AMBQ
Ambiq Micro, Inc.
|
BEARISH | $531.38M | - | -29.4% | -50.3% | $25.36 | |
|
HKD
AMTD Digital Inc.
|
NEUTRAL | $531.13M | 9.39 | 25.4% | 40.2% | $1.69 | Compare |
|
MLAB
Mesa Laboratories, Inc.
|
BEARISH | $540.6M | 150.54 | 2.2% | 1.5% | $97.85 | Compare |
|
CINT
CI&T Inc.
|
BULLISH | $546.08M | 14.1 | 13.8% | 8.3% | $4.23 | Compare |
|
RDVT
Red Violet, Inc.
|
NEUTRAL | $556.21M | 43.32 | 14.0% | 14.6% | $39.42 | Compare |
AMBQ
Ambiq Micro, Inc.
BEARISH
Mkt Cap
$531M
P/E
-
ROE
-29.4%
Price
$25.36
Recent Insider Trading
Insider buy and sell transactions from the last 6 months
| Date | Insider | Position | Transaction | Shares | Value |
|---|---|---|---|---|---|
| 2026-03-06 | WINZELER JEFFREY G | Chief Financial Officer | Stock Award | 41,728 | - |
| 2026-03-06 | ESAKA FUMIHIDE | Chief Executive Officer | Stock Award | 160,616 | - |
| 2026-03-06 | HANSON SCOTT MCLEAN PH.D. | Chief Technology Officer | Stock Award | 80,308 | - |
| 2026-03-06 | CHEN SEAN CHIHHSIANG | President | Stock Award | 64,246 | - |
| 2026-02-18 | HSIEH WEN HSUAN | Director | Option Exercise | 238,931 | $3,010,531 |
| 2026-01-26 | TAUTGES JOSEPH A | Director | Sale | 7,800 | $241,800 |
| 2026-01-26 | HANSON SCOTT MCLEAN PH.D. | Chief Technology Officer | Sale | 10,000 | $310,000 |
| 2025-10-07 | ESAKA FUMIHIDE | Chief Executive Officer | Option Exercise | 53,660 | $315,521 |
| 2025-10-02 | WINZELER JEFFREY G | Chief Financial Officer | Stock Award | 52,667 | - |
| 2025-10-02 | ESAKA FUMIHIDE | Chief Executive Officer | Stock Award | 159,907 | - |
| 2025-10-02 | HANSON SCOTT MCLEAN PH.D. | Chief Financial Officer | Stock Award | 83,819 | - |
| 2025-10-02 | CHEN SEAN CHIHHSIANG | President | Stock Award | 56,029 | - |
WINZELER JEFFREY G
Chief Financial Officer
2026-03-06
41,728 shares
ESAKA FUMIHIDE
Chief Executive Officer
2026-03-06
160,616 shares
HANSON SCOTT MCLEAN PH.D.
Chief Technology Officer
2026-03-06
80,308 shares
CHEN SEAN CHIHHSIANG
President
2026-03-06
64,246 shares
HSIEH WEN HSUAN
Director
2026-02-18
238,931 shares
·
$3,010,531
TAUTGES JOSEPH A
Director
2026-01-26
7,800 shares
·
$241,800
HANSON SCOTT MCLEAN PH.D.
Chief Technology Officer
2026-01-26
10,000 shares
·
$310,000
ESAKA FUMIHIDE
Chief Executive Officer
2025-10-07
53,660 shares
·
$315,521
WINZELER JEFFREY G
Chief Financial Officer
2025-10-02
52,667 shares
ESAKA FUMIHIDE
Chief Executive Officer
2025-10-02
159,907 shares
HANSON SCOTT MCLEAN PH.D.
Chief Financial Officer
2025-10-02
83,819 shares
CHEN SEAN CHIHHSIANG
President
2025-10-02
56,029 shares
Insider transactions can signal confidence or concerns about company prospects
Wall Street Analysts
Professional analyst ratings and price targets
Consensus
BUY
4 analysts
UBS
2025-10-27
Neutral
Neutral
Past News Coverage
Recent headlines mentioning AMBQ from our newsroom.
Newest → oldest
No matching news yet.